Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-13
DOI
10.1038/srep15134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Promises and Pitfalls in Erythopoietin-Mediated Tissue Protection
- (2016) Carla Cerami Hand et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin
- (2015) Massimo Collino et al. PHARMACOLOGY & THERAPEUTICS
- A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice
- (2014) M Collino et al. BRITISH JOURNAL OF PHARMACOLOGY
- Erythropoietin Signaling: A Novel Regulator of White Adipose Tissue Inflammation During Diet-Induced Obesity
- (2014) M. Alnaeeli et al. DIABETES
- Nitric oxide and hypoxia stimulate erythropoietin receptor via MAPK kinase in endothelial cells
- (2014) Bojana B. Beleslin Cokic et al. MICROVASCULAR RESEARCH
- Erythropoietin-Derived Nonerythropoietic Peptide Ameliorates Experimental Autoimmune Neuritis by Inflammation Suppression and Tissue Protection
- (2014) Yuqi Liu et al. PLoS One
- Physiology and Pharmacology of Erythropoietin
- (2014) Wolfgang Jelkmann TRANSFUSION MEDICINE AND HEMOTHERAPY
- PPAR and Sirt1 Mediate Erythropoietin Action in Increasing Metabolic Activity and Browning of White Adipocytes to Protect Against Obesity and Metabolic Disorders
- (2013) L. Wang et al. DIABETES
- Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
- (2013) Andrew E. Hogan et al. DIABETOLOGIA
- Erythropoietin and the heart: Physiological effects and the therapeutic perspective
- (2013) Fabian Sanchis-Gomar et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury
- (2013) Willem G van Rijt et al. Journal of Translational Medicine
- Unknown
- (2013) Lara Heij et al. MOLECULAR MEDICINE
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Obesity and Metabolic Comorbidities: Environmental Diseases?
- (2013) Carla Lubrano et al. Oxidative Medicine and Cellular Longevity
- Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia
- (2012) Akinori Hara et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effects of peroxisome proliferator-activated receptor-γ agonists on the generation of microparticles by monocytes/macrophages
- (2012) Tommaso Neri et al. CARDIOVASCULAR RESEARCH
- Effects of Erythropoietin on Glucose Metabolism
- (2012) E. Mikolás et al. HORMONE AND METABOLIC RESEARCH
- Cocoa polyphenols suppress adipogenesis in vitro and obesity in vivo by targeting insulin receptor
- (2012) S Y Min et al. INTERNATIONAL JOURNAL OF OBESITY
- The cellular and signaling networks linking the immune system and metabolism in disease
- (2012) Olivia Osborn et al. NATURE MEDICINE
- The erythropoietin-derived peptide ARA290 reverses mechanical allodynia in the neuritis model
- (2012) K.G.T. Pulman et al. NEUROSCIENCE
- Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice
- (2011) Derya Sargin et al. BMC BIOLOGY
- Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy
- (2011) Carmel M. McVicar et al. DIABETES
- Impact of the erythropoietin-derived peptide mimetic Epotris on the histopathological consequences of status epilepticus
- (2011) Christina Zellinger et al. EPILEPSY RESEARCH
- Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways
- (2011) Manfred Nairz et al. IMMUNITY
- Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice
- (2011) S D Premaratna et al. INTERNATIONAL JOURNAL OF OBESITY
- The Effects of Erythropoietin Dose Titration during High-Fat Diet-Induced Obesity
- (2011) Amanda Foskett et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Inflammatory links between obesity and metabolic disease
- (2011) Carey N. Lumeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production
- (2011) Ruifeng Teng et al. Nature Communications
- Erythropoietin Over-Expression Protects against Diet-Induced Obesity in Mice through Increased Fat Oxidation in Muscles
- (2009) Pernille Hojman et al. PLoS One
- Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth
- (2009) Junghyo Jo et al. PLoS Computational Biology
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
- (2008) Adilson Guilherme et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin
- (2008) M. Brines et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started